PROTEIMER
Live / Applied — Non-final action mailed (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 07 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99431659
- Mark type
- Stylized text
- Filed
- 07 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations and therapeutic proteins for medical use, biologic preparations for the treatment of neurological, oncological, metabolic, and immunological disorders, aptamer-based therapeutic agents, protein-based drug candidates and antibody mimetics for medical purposes.
- Class 042 — Scientific and technological services: Scientific and technological research and development in the field of biotechnology and pharmaceutical development, research and development of protein-based therapeutics, aptamer-based drug discovery platforms, and biologic drug delivery systems, design and development of biologically active molecules for therapeutic use, providing information in the field of scientific research and development in biotechnology.
Owner
- CrossLife Technologies Inc., Carlsbad, US
- HyunDae Cho, Carlsbad, CA
Prosecution history
- 26 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION WRITTEN
- 25 Feb 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Oct 2025 — NEW APPLICATION ENTERED